Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
Researchers from McGill University found that nurses who receive 40 minutes of bright light exposure prior to their night shifts experience less fatigue and commit fewer mistakes. Following their shifts, the nurses also slept better.
Read Full NewsU.S. Health Secretary Robert F. Kennedy Jr. on Thursday issued a new charter for a CDC vaccine advisory committee that expands the role of the panel to include a focus on...
Growing antimicrobial resistance is prompting renewed interest in phage therapy, with preliminary data indicating improved outcomes when combined with standard antibiotics.
Debate is growing over whether national policy decisions can meet the criteria for global health emergencies, as projections suggest major setbacks in infectious disease control.
There are no approved medications for methamphetamine use disorder, but phase 3 trial results suggest the generic antidepressant mirtazapine may offer modest but significant reductions in use.
A US ecologic study finds higher cancer mortality in counties closer to nuclear plants, but results reflect association and require cautious clinical interpretation.
Modern techniques have greatly reduced the heart disease risks historically tied to radiotherapy for left-sided breast cancer, a large cohort study suggests.
Certain social risk factors are linked to higher costs of healthcare among patients.
1.
Prostate cancer explained: From antigen tests to treatment options
2.
Alcohol Causes Cancer. We Should Be Drinking Less.
3.
Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma
4.
Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.
5.
Experts Debate AQUILA Trial Findings in Smoldering Multiple Myeloma
1.
Radiation in Oncology: Advances, Applications, and Accessibility
2.
Beyond the Blood: Expanding CAR T-Cell Therapy to Solid Tumors- A New Era of Precision Oncology
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
A Comprehensive Guide to Carcinoma in Situ: Types, Risks, and Preventive Measures
5.
Beyond the Battle: Navigating Life After Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge